Answers are grounded in this paper and cite their sources.
T cells at the irradiated tumor site generated a suboptimal systemic antitumor response and the loss of abscopal responses. Therefore, this report maximizes the potential synergy between radiotherapy and αPD-1 immunotherapy, information that will benefit clinical combinations of radiotherapy and immune checkpoint blockade.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: